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LIPOSOMAL BUPIVACAINE IN TOTAL KNEE ARTHROPLASTY: PRELIMINARY RESULTS 
OF A TWO-SURGEON, RETROSPECTIVE STUDY 
 
Hayden B. Rockson, MD, MA1, Jeffrey N. Metzmaker, MD1, David C. Ayers, MD1, Anthony L. 
Schwagerl, MD, PhD2 
1Department of Orthopedic Surgery, UMass Memorial Medical Center; 2Long Island 
Anesthesiologists 
 
INTRODUCTION: Liposomal bupivacaine (LB) is a slowly degrading preparation that provides 
local anesthesia for up to 72 hours. It targets the site directly responsible for pain sensation, 
with no associated motor blockade. In total knee arthroplasty (TKA), it may have superior 
outcomes to anesthesia with regional nerve block. 
 
METHODS: Our surgeons began using LB in TKA patients in 2013. All patients following each 
surgeon’s LB start date were the experimental group. An equivalent number of patients prior to 
2013 served as the control group. All control group patients received a preoperative femoral 
nerve block, and all experimental group patients received peri- and intra-articular LB, delivered 
intraoperatively. All other surgical and anesthesia interventions were the same. We used 
retrospective chart review to identify patient demographics, time to first ambulation, time to 
discharge, and incidence of postoperative nausea and vomiting. We also recorded opioid 
consumption intraoperatively, in the recovery room, and on the floor.  
 
RESULTS: There were 161 patients in each group. We found no significant difference between 
the two groups with regard to gender, age, weight, preoperative opioid exposure, side of 
procedure, type of anesthesia (general vs. spinal), or ASA status. On average, LB patients 
consumed 29.2% less opioid after leaving the recovery room (p<0.0001), and required 24.4% 
less opioid in the entire perioperative period (p<0.0001). LB patients ambulated an average of 
4.3 hours sooner (p<0.0001), and were discharged an average of 14.9 hours earlier (p<0.0001). 
 
DISCUSSION AND CONCLUSION: With increasing focus on the cost of TKA, there is strong 
incentive to manage costs associated with the procedure. Additionally, all patients, regardless of 
comorbid conditions, can benefit from limited exposure to narcotic pain medication. Our results 
indicate that LB decreases total systemic opioid requirement, time to first ambulation, and time 
to discharge from the hospital. 
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